We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

39 hedge funds and large institutions have $126M invested in Q32 Bio in 2024 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 5 increasing their positions, 14 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more capital invested

Capital invested by funds: $11.4M → $126M (+$114M)

228.24% more ownership

Funds ownership: 1.8% → 230.04% (+228%)

32% less funds holding

Funds holding: 57 → 39 (-18)

57% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 30

64% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 14

Holders
39
Holders Change
-18
Holders Change %
-31.58%
% of All Funds
0.56%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
5
Reduced
14
Closed
30
Calls
$197K
Puts
–
Net Calls
+$197K
Net Calls Change
+$176K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$31M
2
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
+$28.8M
3
CG
Carlyle Group
District of Columbia
+$15.2M
4
VC
Vivo Capital
California
+$4.82M
5
AVM
Arch Venture Management
Illinois
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
NM
Newtyn Management
New York
-$851K
2
BCM
BML Capital Management
Indiana
-$230K
3
BlackRock
BlackRock
New York
-$220K
4
GKFF
George Kaiser Family Foundation
Oklahoma
-$186K
5
Renaissance Technologies
Renaissance Technologies
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
51
Assenagon Asset Management
Luxembourg
– -$22.7K -2,076 Closed
AIS
52
American Investment Services
Massachusetts
– -$22.5K -2,053 Closed
VF
53
Virtu Financial
New York
– -$21K -1,877 Closed
SIA
54
Schechter Investment Advisors
Michigan
– -$18.1K -1,655 Closed
Goldman Sachs
55
Goldman Sachs
New York
– -$15.1K -1,381 Closed
Jane Street
56
Jane Street
New York
– -$14.4K -1,314 Closed
Charles Schwab
57
Charles Schwab
California
– -$13.4K -1,221 Closed
Mariner
58
Mariner
Kansas
– -$12.1K -1,102 Closed
Bank of New York Mellon
59
Bank of New York Mellon
New York
– -$11.8K -1,080 Closed
Millennium Management
60
Millennium Management
New York
– -$10.5K -960 Closed
HSBC Holdings
61
HSBC Holdings
United Kingdom
– -$9.32K -863 Closed
RJA
62
Raymond James & Associates
Florida
– -$7.86K -718 Closed
DCM
63
Dimension Capital Management
Florida
– -$6.66K -608 Closed
Corient Private Wealth
64
Corient Private Wealth
Florida
– -$6.08K -556 Closed
TYCC
65
Texas Yale Capital Corp
Florida
– -$6.08K -556 Closed
AWM
66
Ameliora Wealth Management
Switzerland
– -$912 -83 Closed
ASN
67
Advisory Services Network
Georgia
– -$423 -39 Closed
IRC
68
Investors Research Corp
Georgia
– -$97 -9 Closed
1 2
3

QTTB Hedge Fund Activity: Q1 2024 in Review

39 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2024, worth a combined $126M — up 1,000% from $11.4M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of QTTB and 13 opened new positions — a net loss of 17 holders — while 14 trimmed existing stakes and 5 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $31M. The largest seller was Newtyn Management, exiting entirely with an estimated $851K sold.

  • 39 institutional investors held Q32 Bio (QTTB) as of Q1 2024, down from 57 in Q4 2023.
  • Funds reported $126M of Q32 Bio stock for Q1 2024, up 1,000% quarter-over-quarter.
  • 13 funds opened new Q32 Bio positions in Q1 2024 and 30 closed out, a net change of -17 holders.
  • The largest Q32 Bio buyer in Q1 2024 was OrbiMed, an estimated $31M added.
  • The largest Q32 Bio seller in Q1 2024 was Newtyn Management, an estimated $851K sold.

Based on aggregated 13F filings for Q1 2024.